\relax 
\providecommand\zref@newlabel[2]{}
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\bibstyle{pnas-new}
\citation{Huang2006}
\citation{Phillips2008}
\citation{Mortazavi2008}
\citation{Schwarz2012}
\citation{VanWolfswinkel2014,Scimone2014}
\citation{Brem2002,Schadt2003,Li2006,King2014}
\citation{Hughes2000}
\citation{VanDriessche2005}
\citation{Dixit2016}
\citation{Angeles-Albores2016a}
\citation{Epstein2001,Shen2006,Shao2009,Jiang2001}
\citation{Loenarz2011}
\citation{Jiang1996}
\citation{Jiang2001}
\citation{Powell-Coffman1998}
\citation{Huang1996}
\citation{Kaelin2008}
\citation{Ma2012}
\select@language{english}
\@writefile{toc}{\select@language{english}}
\@writefile{lof}{\select@language{english}}
\@writefile{lot}{\select@language{english}}
\zref@newlabel{mdf@pagelabel-1}{\default{\caption@xref {??}{ on input line 193}}\page{1}\abspage{1}\mdf@pagevalue{1}}
\pgfsyspdfmark {pgfid1}{20424130}{7852432}
\pgfsyspdfmark {pgfid2}{19981762}{2393170}
\citation{Angeles-Albores2016a}
\citation{Shao2009}
\citation{Yeung2001}
\@writefile{lof}{\contentsline {figure}{\numberline {1}{\ignorespaces  Genetic and biochemical representation of the hypoxia pathway in \emph  {C.~elegans}{}. Red arrows are arrows that lead to inhibition of HIF-1{}, and blue arrows are arrows that increase HIF-1{} activity or are the result of HIF-1{} activity. EGL-9{} is known to exert \unhbox \voidb@x \hbox {\emph  {vhl-1}}-dependent and independent repression on HIF-1{} as shown in the genetic diagram. The \unhbox \voidb@x \hbox {\emph  {vhl-1}}-independent repression of HIF-1{} by EGL-9{} is denoted by a dashed line and is not dependent on the hydroxylating activity of EGL-9{}. Technically, RHY-1 inhibits CYSL-1, which in turn inhibits EGL-9, but this interaction was abbreviated in the genetic diagram for clarity. \relax }}{2}{figure.caption.1}}
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{fig:pathway}{{1}{2}{Genetic and biochemical representation of the hypoxia pathway in \cel {}. Red arrows are arrows that lead to inhibition of \hifp {}, and blue arrows are arrows that increase \hifp {} activity or are the result of \hifp {} activity. \eglp {} is known to exert \gene {vhl-1}-dependent and independent repression on \hifp {} as shown in the genetic diagram. The \gene {vhl-1}-independent repression of \hifp {} by \eglp {} is denoted by a dashed line and is not dependent on the hydroxylating activity of \eglp {}. Technically, RHY-1 inhibits CYSL-1, which in turn inhibits EGL-9, but this interaction was abbreviated in the genetic diagram for clarity. \relax }{figure.caption.1}{}}
\newlabel{sub:summary}{{}{2}{}{figure.caption.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2}{\ignorespaces  Analysis workflow. After sequencing, reads are quantified using Kallisto. Bars show estimated counts for each isoform. Differential expression is calculated using Sleuth, which outputs one $\beta $ coefficient per isoform per genotype. $\beta $ coefficients are analogous to the natural logarithm of the fold-change relative to a wild-type control. Downstream analyses are performed with $\beta $ coefficients that are statistically significantly different from 0. Q-values less than 0.1 are considered statistically different from 0. \relax }}{2}{figure.caption.2}}
\newlabel{fig:explain}{{2}{2}{Analysis workflow. After sequencing, reads are quantified using Kallisto. Bars show estimated counts for each isoform. Differential expression is calculated using Sleuth, which outputs one $\beta $ coefficient per isoform per genotype. $\beta $ coefficients are analogous to the natural logarithm of the fold-change relative to a wild-type control. Downstream analyses are performed with $\beta $ coefficients that are statistically significantly different from 0. Q-values less than 0.1 are considered statistically different from 0. \relax }{figure.caption.2}{}}
\newlabel{sub:Clustering}{{}{2}{}{table.caption.3}{}}
\pgfsyspdfmark {pgfid3}{20276674}{2393170}
\citation{Angeles-Albores2016a}
\citation{Epstein2001,Shen2006}
\@writefile{lot}{\contentsline {table}{\numberline {1}{\ignorespaces Number of differentially expressed genes in each mutant with respect to wildtype (N2).\relax }}{3}{table.caption.3}}
\newlabel{tab:genes}{{1}{3}{Number of differentially expressed genes in each mutant with respect to wildtype (N2).\relax }{table.caption.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3}{\ignorespaces  Principal component analysis of various \emph  {C.~elegans}{} mutants. Genotypes that have an constitutive hypoxia response (i.e. \unhbox \voidb@x \hbox {\emph  {egl-9}}(lf){}) cluster far from genotypes that do not have a hypoxic response (i.e. \unhbox \voidb@x \hbox {\emph  {hif-1(lf)}}{}) along PCA Dimension 1. PCA Dimension 2 separates genotypes that do not participate hypoxic response pathway. \relax }}{3}{figure.caption.4}}
\newlabel{fig:pca}{{3}{3}{Principal component analysis of various \cel {} mutants. Genotypes that have an constitutive hypoxia response (i.e. \egl {}) cluster far from genotypes that do not have a hypoxic response (i.e. \hif {}) along PCA Dimension 1. PCA Dimension 2 separates genotypes that do not participate hypoxic response pathway. \relax }{figure.caption.4}{}}
\newlabel{sec:reconstruct}{{}{3}{}{figure.caption.4}{}}
\newlabel{sec:phenotypes}{{}{3}{}{figure.caption.4}{}}
\pgfsyspdfmark {pgfid4}{19981762}{2393170}
\@writefile{lof}{\contentsline {figure}{\numberline {4}{\ignorespaces  Strong transcriptional correlations can be identified between genes that share a positive regulatory connection. \textbf  {A}. We obtained identified isoforms that were differentially expressed in both \unhbox \voidb@x \hbox {\emph  {egl-9}}(lf){} and the \unhbox \voidb@x \hbox {\emph  {rhy-1}}(lf){} mutants, and ranked each isoform according to its $\beta $ coefficient. We plotted the rank of each gene in \unhbox \voidb@x \hbox {\emph  {rhy-1}}(lf){} versus the rank of the same gene in the \unhbox \voidb@x \hbox {\emph  {egl-9}}(lf){} transcriptome. \textbf  {B}. For comparison, we followed the same procedure with the \unhbox \voidb@x \hbox {\emph  {fog-2(lf)}}{} and \unhbox \voidb@x \hbox {\emph  {rhy-1}}(lf){} transcriptomes. \unhbox \voidb@x \hbox {\emph  {fog-2(lf)}}{} is not known to interact with the primary hypoxia pathway. Green, transparent large points mark inliers to the primary regressions (blue lines); red squares mark outliers to the primary regressions and orange lines represent the secondary correlations involving the outliers. \relax }}{4}{figure.caption.5}}
\newlabel{fig:genetic_interactions}{{4}{4}{Strong transcriptional correlations can be identified between genes that share a positive regulatory connection. \textbf {A}. We obtained identified isoforms that were differentially expressed in both \egl {} and the \rhy {} mutants, and ranked each isoform according to its $\beta $ coefficient. We plotted the rank of each gene in \rhy {} versus the rank of the same gene in the \egl {} transcriptome. \textbf {B}. For comparison, we followed the same procedure with the \fog {} and \rhy {} transcriptomes. \fog {} is not known to interact with the primary hypoxia pathway. Green, transparent large points mark inliers to the primary regressions (blue lines); red squares mark outliers to the primary regressions and orange lines represent the secondary correlations involving the outliers. \relax }{figure.caption.5}{}}
\newlabel{sub:decorrelation}{{}{4}{}{figure.caption.6}{}}
\pgfsyspdfmark {pgfid5}{20276674}{2393170}
\citation{Park2012}
\@writefile{lof}{\contentsline {figure}{\numberline {5}{\ignorespaces  (\textbf  {A}) Schematic diagram of an epistasis plot. The X-axis on an epistasis plot is the expected coefficient for a double mutant under an log-additive model (null model). The Y-axis plots deviations from this model. Double mutants that deviate in a systematic manner from the null model exhibit transcriptome-wide epistasis ($s$). To measure $s$, we find the line of best fit and determine its slope. Genes that act log-additively on a phenotype \textbf  {(Ph)} will have $s=0$ (null hypothesis, orange line); whereas genes that act along an unbranched pathway will have $s=-1/2$ (blue line). Strong repression is reflected by $s=-1$ (red line), whereas $s>0$ correspond to synthetic interactions (purple line). (\textbf  {B}) Epistasis plot showing that the \unhbox \voidb@x \hbox {\emph  {egl-9(lf);vhl-1(lf)}}{} transcriptome deviates significantly from a null additive. Points are colored qualitatively according to density (purple---low, yellow---high) and size is inversely proportional to the standard error (S.E.) of the y-axis. The green line is the line of best fit from an orthogonal distance regression. (\textbf  {C}) Comparison of simulated epistatic coefficients against the observed coefficient. Green curve shows the bootstrapped observed transcriptome-wide epistasis coefficient for \unhbox \voidb@x \hbox {\emph  {egl-9}} and \unhbox \voidb@x \hbox {\emph  {vhl-1}}. Dashed green line shows the mean value of the data. Simulations use only the single mutant data to idealize what expression of the double mutant should look like. $x > y$ means that the phenotype of $x$ is observed in a double mutant $x^-y^-$. \relax }}{5}{figure.caption.6}}
\newlabel{fig:egl9epistasis}{{5}{5}{(\textbf {A}) Schematic diagram of an epistasis plot. The X-axis on an epistasis plot is the expected coefficient for a double mutant under an log-additive model (null model). The Y-axis plots deviations from this model. Double mutants that deviate in a systematic manner from the null model exhibit transcriptome-wide epistasis ($s$). To measure $s$, we find the line of best fit and determine its slope. Genes that act log-additively on a phenotype \textbf {(Ph)} will have $s=0$ (null hypothesis, orange line); whereas genes that act along an unbranched pathway will have $s=-1/2$ (blue line). Strong repression is reflected by $s=-1$ (red line), whereas $s>0$ correspond to synthetic interactions (purple line). (\textbf {B}) Epistasis plot showing that the \eglvhl {} transcriptome deviates significantly from a null additive. Points are colored qualitatively according to density (purple---low, yellow---high) and size is inversely proportional to the standard error (S.E.) of the y-axis. The green line is the line of best fit from an orthogonal distance regression. (\textbf {C}) Comparison of simulated epistatic coefficients against the observed coefficient. Green curve shows the bootstrapped observed transcriptome-wide epistasis coefficient for \gene {egl-9} and \gene {vhl-1}. Dashed green line shows the mean value of the data. Simulations use only the single mutant data to idealize what expression of the double mutant should look like. $x > y$ means that the phenotype of $x$ is observed in a double mutant $x^-y^-$. \relax }{figure.caption.6}{}}
\newlabel{sub:topology}{{}{5}{}{figure.caption.7}{}}
\pgfsyspdfmark {pgfid6}{19981762}{2393170}
\citation{Ackerman2012,Romney2011}
\@writefile{lof}{\contentsline {figure}{\numberline {6}{\ignorespaces  Theoretically, transcriptomes can be used to order genes in a pathway under certain assumptions. Arrows in the diagrams above are intended to show the direction of flow, and do not indicate valence. \textbf  {A}. A linear pathway in which \unhbox \voidb@x \hbox {\emph  {rhy-1}} is the only gene controlling \unhbox \voidb@x \hbox {\emph  {egl-9}}, which in turn controls \unhbox \voidb@x \hbox {\emph  {hif-1}} does not contain information to infer the order between genes. \textbf  {B}. If \unhbox \voidb@x \hbox {\emph  {rhy-1}} and \unhbox \voidb@x \hbox {\emph  {egl-9}} have transcriptomic effects that are separable from \unhbox \voidb@x \hbox {\emph  {hif-1}}, then the \unhbox \voidb@x \hbox {\emph  {rhy-1}} transcriptome should contain contributions from \unhbox \voidb@x \hbox {\emph  {egl-9}}, \unhbox \voidb@x \hbox {\emph  {hif-1}} and \unhbox \voidb@x \hbox {\emph  {egl-9}}- and \unhbox \voidb@x \hbox {\emph  {hif-1}}-independent pathways. This pathway contains enough information to infer order. \textbf  {C}. If a pathway is branched both upstream and downstream, transcriptomes will show even faster decorrelation. Nodes that are separated by many edges may begin to behave almost independently of each other with marginal transcriptomic overlap or correlation. \textbf  {D}. The hypoxia pathway can be ordered. We hypothesize the rapid decay in correlation is due to a mixture of upstream and downstream branching that happens along this pathway. Bars show the standard error of the weighted coefficient from the Monte Carlo Markov Chain computations. \relax }}{6}{figure.caption.7}}
\newlabel{fig:decorrelation}{{6}{6}{Theoretically, transcriptomes can be used to order genes in a pathway under certain assumptions. Arrows in the diagrams above are intended to show the direction of flow, and do not indicate valence. \textbf {A}. A linear pathway in which \gene {rhy-1} is the only gene controlling \gene {egl-9}, which in turn controls \gene {hif-1} does not contain information to infer the order between genes. \textbf {B}. If \gene {rhy-1} and \gene {egl-9} have transcriptomic effects that are separable from \gene {hif-1}, then the \gene {rhy-1} transcriptome should contain contributions from \gene {egl-9}, \gene {hif-1} and \gene {egl-9}- and \gene {hif-1}-independent pathways. This pathway contains enough information to infer order. \textbf {C}. If a pathway is branched both upstream and downstream, transcriptomes will show even faster decorrelation. Nodes that are separated by many edges may begin to behave almost independently of each other with marginal transcriptomic overlap or correlation. \textbf {D}. The hypoxia pathway can be ordered. We hypothesize the rapid decay in correlation is due to a mixture of upstream and downstream branching that happens along this pathway. Bars show the standard error of the weighted coefficient from the Monte Carlo Markov Chain computations. \relax }{figure.caption.7}{}}
\newlabel{sub:hifoh}{{}{6}{}{figure.caption.7}{}}
\newlabel{sec:discussion}{{}{6}{}{figure.caption.8}{}}
\pgfsyspdfmark {pgfid7}{20276674}{2393170}
\citation{Ackerman2012,Romney2011,Luhachack2012}
\citation{Romney2011,Ackerman2012}
\citation{Luhachack2012}
\citation{Shao2010}
\citation{Budde2010}
\citation{Kim2004}
\citation{Chintala2012}
\citation{Wang1993}
\@writefile{lof}{\contentsline {figure}{\numberline {7}{\ignorespaces  \textbf  {A}. 56{} genes in \emph  {C.~elegans}{} exhibit non-classical epistasis in the hypoxiapathway, characterized by opposite effects on gene expression, relative to the wild-type, of of the \unhbox \voidb@x \hbox {\emph  {vhl-1}}(lf){} compared to \unhbox \voidb@x \hbox {\emph  {egl-9}}(lf){} (or \unhbox \voidb@x \hbox {\emph  {rhy-1}}(lf){}) mutants. Shown are a random selection of 15 the 56{} genes for illustrative purposes. \textbf  {B}. Genes that behave non-canonically have a consistent pattern. \unhbox \voidb@x \hbox {\emph  {vhl-1}}(lf){} mutants have an opposite effect to \unhbox \voidb@x \hbox {\emph  {egl-9}}(lf){}, but \unhbox \voidb@x \hbox {\emph  {egl-9}} remains epistatic to \unhbox \voidb@x \hbox {\emph  {vhl-1}} and loss-of-function mutations in \unhbox \voidb@x \hbox {\emph  {hif-1}} suppress the \unhbox \voidb@x \hbox {\emph  {egl-9}}(lf){} phenotype. Asterisks show $\beta $ values significantly different from 0 relative to wild-type ($q<10^{-1}$). \relax }}{7}{figure.caption.8}}
\newlabel{fig:hif1oh}{{7}{7}{\textbf {A}. \hifohtargets {} genes in \cel {} exhibit non-classical epistasis in the hypoxiapathway, characterized by opposite effects on gene expression, relative to the wild-type, of of the \vhl {} compared to \egl {} (or \rhy {}) mutants. Shown are a random selection of 15 the \hifohtargets {} genes for illustrative purposes. \textbf {B}. Genes that behave non-canonically have a consistent pattern. \vhl {} mutants have an opposite effect to \egl {}, but \gene {egl-9} remains epistatic to \gene {vhl-1} and loss-of-function mutations in \gene {hif-1} suppress the \egl {} phenotype. Asterisks show $\beta $ values significantly different from 0 relative to wild-type (\qval {1}). \relax }{figure.caption.8}{}}
\pgfsyspdfmark {pgfid8}{19981762}{2393170}
\citation{Goentoro2009a}
\citation{Hart2012,Hart2013}
\citation{Dixit2016,Angeles-Albores2016a}
\citation{Dixit2016}
\citation{Angeles-Albores2016a}
\@writefile{lof}{\contentsline {figure}{\numberline {8}{\ignorespaces  A hypothetical model showing a mechanism where HIF-1{}-hydroxyl antagonises HIF-1{}. \textbf  {A}. Diagram showing that RHY-1 activates EGL-9. EGL-9 hydroxylates HIF-1 in an oxygen dependent fashion. Under normoxia, HIF-1 is rapidly hydroxylated and only slowly does hydroxylated HIF-1 return to its original state. EGL-9 can also inhibit HIF-1 in an oxygen-independent fashion. HIF-1 hydroxyl is rapidly degraded in a VHL-1 dependent fashion. In our model, HIF-1 and HIF-1 hydroxyl have opposing effects on transcription. The width of the arrows represents the rates under normoxic conditions. \textbf  {B}. Table showing the effects of loss-of-function mutations on HIF-1 and HIF-1 hydroxyl activity, showing how this can potentially explain the behavior of \unhbox \voidb@x \hbox {\emph  {ftn-1}} in each case. S.S = Steady-state. \relax }}{8}{figure.caption.9}}
\newlabel{fig:hif1oh_table}{{8}{8}{A hypothetical model showing a mechanism where \hifp {}-hydroxyl antagonises \hifp {}. \textbf {A}. Diagram showing that RHY-1 activates EGL-9. EGL-9 hydroxylates HIF-1 in an oxygen dependent fashion. Under normoxia, HIF-1 is rapidly hydroxylated and only slowly does hydroxylated HIF-1 return to its original state. EGL-9 can also inhibit HIF-1 in an oxygen-independent fashion. HIF-1 hydroxyl is rapidly degraded in a VHL-1 dependent fashion. In our model, HIF-1 and HIF-1 hydroxyl have opposing effects on transcription. The width of the arrows represents the rates under normoxic conditions. \textbf {B}. Table showing the effects of loss-of-function mutations on HIF-1 and HIF-1 hydroxyl activity, showing how this can potentially explain the behavior of \gene {ftn-1} in each case. S.S = Steady-state. \relax }{figure.caption.9}{}}
\pgfsyspdfmark {pgfid9}{20276674}{2393170}
\citation{Brenner1974}
\citation{Picelli2014}
\citation{Picelli2014}
\citation{Bray2016}
\citation{Pimentel2016}
\citation{McKinney2011,Oliphant2007,Pedregosa2012,Salvatier2015,VanDerWalt2011,Hunter2007,Angeles-Albores2016,Waskom}
\citation{Perez2007}
\citation{Salvatier2015}
\citation{Angeles-Albores106369,Angeles-Albores2016}
\@writefile{toc}{\contentsline {matmethods@section}{\numberline {1}Materials and Methods}{9}{matmethods@section.1}}
\newlabel{eq:epistasis_coef}{{2}{9}{}{equation.0.2}{}}
\newlabel{eq:free_model}{{3}{9}{}{equation.0.3}{}}
\pgfsyspdfmark {pgfid10}{19981762}{2393170}
\bibdata{citations}
\bibcite{Huang2006}{{1}{}{{}}{{}}}
\bibcite{Phillips2008}{{2}{}{{}}{{}}}
\bibcite{Mortazavi2008}{{3}{}{{}}{{}}}
\bibcite{Schwarz2012}{{4}{}{{}}{{}}}
\bibcite{VanWolfswinkel2014}{{5}{}{{}}{{}}}
\bibcite{Scimone2014}{{6}{}{{}}{{}}}
\bibcite{Brem2002}{{7}{}{{}}{{}}}
\bibcite{Schadt2003}{{8}{}{{}}{{}}}
\bibcite{Li2006}{{9}{}{{}}{{}}}
\bibcite{King2014}{{10}{}{{}}{{}}}
\bibcite{Hughes2000}{{11}{}{{}}{{}}}
\bibcite{VanDriessche2005}{{12}{}{{}}{{}}}
\bibcite{Dixit2016}{{13}{}{{}}{{}}}
\bibcite{Angeles-Albores2016a}{{14}{}{{}}{{}}}
\bibcite{Epstein2001}{{15}{}{{}}{{}}}
\bibcite{Shen2006}{{16}{}{{}}{{}}}
\bibcite{Shao2009}{{17}{}{{}}{{}}}
\bibcite{Jiang2001}{{18}{}{{}}{{}}}
\bibcite{Loenarz2011}{{19}{}{{}}{{}}}
\bibcite{Jiang1996}{{20}{}{{}}{{}}}
\bibcite{Powell-Coffman1998}{{21}{}{{}}{{}}}
\bibcite{Huang1996}{{22}{}{{}}{{}}}
\bibcite{Kaelin2008}{{23}{}{{}}{{}}}
\bibcite{Ma2012}{{24}{}{{}}{{}}}
\bibcite{Yeung2001}{{25}{}{{}}{{}}}
\bibcite{Park2012}{{26}{}{{}}{{}}}
\bibcite{Ackerman2012}{{27}{}{{}}{{}}}
\bibcite{Romney2011}{{28}{}{{}}{{}}}
\bibcite{Luhachack2012}{{29}{}{{}}{{}}}
\bibcite{Shao2010}{{30}{}{{}}{{}}}
\bibcite{Budde2010}{{31}{}{{}}{{}}}
\bibcite{Kim2004}{{32}{}{{}}{{}}}
\bibcite{Chintala2012}{{33}{}{{}}{{}}}
\bibcite{Wang1993}{{34}{}{{}}{{}}}
\bibcite{Goentoro2009a}{{35}{}{{}}{{}}}
\bibcite{Hart2012}{{36}{}{{}}{{}}}
\bibcite{Hart2013}{{37}{}{{}}{{}}}
\bibcite{Brenner1974}{{38}{}{{}}{{}}}
\bibcite{Picelli2014}{{39}{}{{}}{{}}}
\bibcite{Bray2016}{{40}{}{{}}{{}}}
\bibcite{Pimentel2016}{{41}{}{{}}{{}}}
\bibcite{McKinney2011}{{42}{}{{}}{{}}}
\bibcite{Oliphant2007}{{43}{}{{}}{{}}}
\bibcite{Pedregosa2012}{{44}{}{{}}{{}}}
\bibcite{Salvatier2015}{{45}{}{{}}{{}}}
\bibcite{VanDerWalt2011}{{46}{}{{}}{{}}}
\bibcite{Hunter2007}{{47}{}{{}}{{}}}
\bibcite{Angeles-Albores2016}{{48}{}{{}}{{}}}
\bibcite{Waskom}{{49}{}{{}}{{}}}
\bibcite{Perez2007}{{50}{}{{}}{{}}}
\bibcite{Angeles-Albores106369}{{51}{}{{}}{{}}}
\xwm@secstopagerange{{10000}{10}}
\providecommand\NAT@force@numbers{}\NAT@force@numbers
\pgfsyspdfmark {pgfid11}{20276674}{2393170}
\newlabel{LastPage}{{}{10}{}{page.10}{}}
\xdef\lastpage@lastpage{10}
\xdef\lastpage@lastpageHy{10}
\newlabel{xwmlastpage}{{1}{10}{Materials and Methods\relax }{equation.0.4}{}}
